Funding period

2025-2027

Investment

$60,000

ABOUT THE PROJECT

Developed through the Society of Gynecologic Oncology of Canada (GOC)’s Rare Cancer Community of Practice, the goal of this project is to establish a rare gynecologic cancer registry, starting with clear cell and mucinous ovarian cancer. This national resource will help patients affected by these cancers by facilitating future projects, linking clinicians with specific disease interests, understanding practices across the country, sharing knowledge, fostering ongoing research collaborations, and helping patients access clinical trials.

By the end of the funding period, the goal for the registry is to facilitate two research projects:

  1. To identify reliable biomarkers to predict response to immune checkpoint blockade in clear cell cancer (project leads Dr. Melica Brodeur and Dr. Susie Lau, Jewish General Hospital);
  2. To assess the diagnostic accuracy of pre-operative circulating tumour DNA in mucinous ovarian cancer (project leads Dr. Elizabeth Tremblay and Dr. Diane Provencher, CHUM).